TODD MILLER: Open Payments
NPI 1811676646 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 59 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $359 · 2025 $1,143
Food & beverage: $1,143
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $188 |
| Edwards Lifesciences Corporation | 4 | $108 |
| Alnylam Pharmaceuticals Inc. | 6 | $102 |
| Merck Sharp & Dohme LLC | 5 | $89 |
| Novo Nordisk Inc | 5 | $86 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Amgen Inc. | 5 | $84 |
| Boston Scientific Corporation | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| PFIZER INC. | 3 | $51 |
Products named: JARDIANCE, ONPATTRO, VERQUVO, Wegovy, REPATHA, FARXIGA, LEQVIO, ELIQUIS.
Industry payments across NY — which companies pay providers there.
